Bright Minds Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions CAD

Scroll to see more
Bright Minds Biosciences Inc. income statement - Annual data in millions CAD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Sep 2024Sep 2023Sep 2022Sep 2021
Revenue & Gross Profit
Revenue0.000.000.000.000.00
Cost of Revenue0.080.000.000.000.00
Gross Profit-0.080.000.000.000.00
Operating Expenses
Research & Development11.081.185.0012.186.31
Selling, General & Administrative2.571.451.232.552.31
Operating Expenses13.822.637.3914.738.62
Operating Income-13.94-2.63-7.39-14.73-8.62
Other Income/Expense
Interest Income1.520.030.000.000.00
Interest Expense0.040.000.000.000.00
Other Income/Expense1.71-0.200.01-0.24-0.18
Income
Income Before Tax-12.23-2.80-7.40-14.96-8.65
Income Tax Expense0.000.000.000.000.00
Net Income-12.23-2.80-7.40-14.96-8.65
Net Income - Continuous Operations-12.23-2.80-7.37-14.960.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-12.12-2.75-7.33-14.960.00
EBIT-13.61-2.63-7.40-14.73-8.62
Depreciation & Amortization0.080.070.07-0.010.00
Earnings Per Share
Basic EPS-2.00-1.00-2.00-6.00-5.00
Diluted EPS-2.00-1.00-2.00-6.00-5.00
Basic Shares Outstanding6.884.313.722.471.79
Diluted Shares Outstanding6.884.313.722.471.79